Issue 10, 2017

PSMA-targeted contrast agents for intraoperative imaging of prostate cancer,

Abstract

Prostate-specific membrane antigen (PSMA) can serve as a molecular cell surface target for the detection and treatment of prostate cancer. Near-infrared (NIR) fluorescence imaging enables highly sensitive, rapid, and non-radioactive imaging of PSMA, though specific targeting still remains a challenge because no optimized contrast agents exist.

Graphical abstract: PSMA-targeted contrast agents for intraoperative imaging of prostate cancer,

Supplementary files

Article information

Article type
Communication
Submitted
13 dez 2016
Accepted
09 jan 2017
First published
13 jan 2017

Chem. Commun., 2017,53, 1611-1614

PSMA-targeted contrast agents for intraoperative imaging of prostate cancer,

K. Bao, J. H. Lee, H. Kang, G. K. Park, G. El Fakhri and H. S. Choi, Chem. Commun., 2017, 53, 1611 DOI: 10.1039/C6CC09781B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements